High pneumococcal DNA load, procalcitonin and suPAR levels correlate to severe disease development in patients with pneumococcal pneumonia
European Journal of Clinical Microbiology & Infectious Diseases
August 18, 2017
Loonen AJM, et al.
Authors assessed several markers of infection (pneumococcal DNA load in blood (real–time LytA PCR), white blood cell (WBC) count, C–reactive protein (CRP), procalcitonin (PCT) and soluble urokinase plasminogen activator receptor (suPAR) levels) for their ability to predict severe disease development in patients with pneumococcal pneumonia. Patients with community–acquired pneumonia (CAP) having higher pneumococcal DNA load, PCT and suPAR values seemed to be at increased risk of developing severe disease (ICU admission and/or death). These biomarkers could be useful tools for triage of patients suspected of having CAP in the emergency department.
Your browser is currently blocking ads. We depend on ad sponsorships in order to keep this site free to the healthcare provider community. Help us keep this site free by turning off your ad blocker.
Turn Off Ad Blocker
We have detected that you are currently blocking ads. We kindly ask that you enable ads when visiting our site. We depend on ad sponsorships in order to keep this site free to the healthcare provider community.